Found: 12
Select item for more details and to access through your institution.
Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells.
- Published in:
- PLoS ONE, 2018, p. 1, doi. 10.1371/journal.pone.0202827
- By:
- Publication type:
- Article
Novel combined therapy based on IL-13-PEG-LCL-SIM and PEG-EV-DOX to reduce murine melanoma aggresiveness in vivo.
- Published in:
- Studia Universitatis Babeş-Bolyai, Biologia, 2021, v. 66, n. 1, p. 13
- By:
- Publication type:
- Article
HIF-1α acts as a molecular target for simvastatin cytotoxicity in B16.F10 melanoma cells cultured under chemically induced hypoxia.
- Published in:
- Oncology Letters, 2017, v. 13, n. 5, p. 3942, doi. 10.3892/ol.2017.5928
- By:
- Publication type:
- Article
Biologically Active Ajuga Species Extracts Modulate Supportive Processes for Cancer Cell Development.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00334
- By:
- Publication type:
- Article
SHIFTING THE BALANCE TOWARDS AN ANTI-TUMORIGENIC MELANOMA MICROENVIRONMENT VIA CO-ADMINISTRATION OF LIPOSOME-ENCAPSULATED SIMVASTATIN AND DMXAA IN VIVO.
- Published in:
- Journal of Experimental & Molecular Biology, 2019, v. 20, n. 3, p. 41
- By:
- Publication type:
- Article
DUAL ROLE OF CANCER-DERIVED EXTRACELLULAR VESICLES IN THE MODULATION OF TUMOR MICROENVIRONMENT.
- Published in:
- Journal of Experimental & Molecular Biology, 2019, v. 20, n. 3, p. 21
- By:
- Publication type:
- Article
TARGETING MELANOMA MICROENVIRONMENT WITH LIPOSOMAL PREDNISOLONE IMPROVED THE THERAPEUTIC OUTCOME OF LIPOSOMAL DOXORUBICIN.
- Published in:
- Journal of Experimental & Molecular Biology, 2019, v. 20, n. 3, p. 20
- By:
- Publication type:
- Article
Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.870347
- By:
- Publication type:
- Article
Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01284-5
- By:
- Publication type:
- Article
The prednisolone phosphate-induced suppression of the angiogenic function of tumor-associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
- Published in:
- Oncology Reports, 2019, v. 42, n. 6, p. 2694, doi. 10.3892/or.2019.7346
- By:
- Publication type:
- Article
A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 10, p. 1526, doi. 10.3390/pharmaceutics13101526
- By:
- Publication type:
- Article
Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo.
- Published in:
- Cancer Science, 2020, v. 111, n. 4, p. 1344, doi. 10.1111/cas.14312
- By:
- Publication type:
- Article